Researchers Detects New AI Method To Treat Crohn’s Disease
Jyotis - Oct 02, 2019
Although it may take the research team a lot of time to improve the accuracy of this method, they can now, at least, pinpoint the reason for Crohn’s disease, as well as help doctors diagnose it earlier.
- Disney To Use AI To Eliminate Gender Stereotype In Its Films
- MIT And IBM Engineers Find A Method To Train AI Faster
- This Startup Introduces Human-Like Robot That Is Difficult To Distinguish
Researchers have recently detected a new AI method that can help doctors get more knowledge about Crohn’s disease, as well as find out how to treat it. For those unknown, this disease is one of the major reasons that make patients inflamed in their digestive tract.
The research was first published in a peer-reviewed open-access medical journal named Genome Medicine. In this research, the authors described how to check genetic signatures of Crohn’s disease in more than 100 people via artificial intelligence (AI).
The advantage of this new method is that they can detect genes relating to this disease, which can’t be previously found out. And therefore, they can predict who will be the next patients of Crohn.
According to Yana Bromberg, the main author of the study, “Our method is not a clinical diagnosis tool, but it generates interesting observations that need to be followed up.” She now works as an Associate Professor of Rutgers University, US.
She added, “Further experimental work could reveal the molecular reasons behind some forms of Crohn’s disease and, potentially, lead to its better treatment.”
There are about 780,000 patients in the United States, who are suffering from Crohn’s disease.
Though symptoms may appear in any position in patients’ bodies, any part in the gastrointestinal tract can be chronically inflamed. In addition, patients can suffer from some issues concerning skin or joint pain. The US National Library of Medicine reports that, for children, they can even face growth problems.
The researchers gathered 111 people to analyze genetic variants. Among these 111 people, there are 64 ones who suffer from Crohn’s disease. They then leveraged AI techniques to determine patients’ genes that have functions affected more than those in healthy people, or vice versa.
Although it may take the research team a lot of time to improve the accuracy of this method, they can now, at least, pinpoint the reason for Crohn’s disease, as well as help doctors diagnose it earlier. Bromberg stated, “We can use the knowledge gained from this study to similarly model other genetically-linked diseases.”